Baotou Dongbao Bio-Tech Co.,Ltd

¥4.90As of Sun 8 Nov 2026, 12:00 UTC
SZSE:300239Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR (4.69%)
Div yield 0.24%
ROE 3.49%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.28
PE TTM 49.33
TSR TTM (11.82%)
Mkt cap ¥2.857B
ROIC 2.98%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥4.89
(0.29%)
(95.77%)
Hold 6|3|11|4|11
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.08
0.08
0.08
0.09
26.17%
24.46%
11.46%
25.36%
Revenue¥M
153.2
152.7
149.5
149.7
(4.97%)
(7.20%)
(6.89%)
(4.74%)
Peers (US$428.3M)
Cap (US$)
PE
436.6M
—
428.5M
25.09x
414.2M
99.10x
Capital
TTM
5Y
10Y
Leveragex
0.914
0.224
0.194
EBIT/Intx
0.514
2.248
2.066
Own earn%
(66.43)
(2.48)
(5.54)
Sh yield%
28.13
49.07
48.71
Owners
Insiders/Inst%
13.81
26.28
Short interest%
0.66
SBC / revenue%
1.12
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
8
Op margin range%
1–10
$1 testx
0.1
Incr. ROIC%
12